| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:06 | GE HealthCare stock price target raised to $95 by Stifel on strong demand | ||
| 14:42 | Inogen launches Aurora CPAP masks, expanding into sleep apnea market | ||
| 14:42 | Reliance Global to acquire majority stake in breath diagnostics firm | ||
| 14:42 | Blood test reduces preterm births and newborn complications | ||
| 14:42 | Sarepta submits clinical trial application for Huntington's disease drug | ||
| 14:42 | Sensus Healthcare appoints GE HealthCare executive to board of directors | ||
| 14:42 | NCR Voyix unveils next-generation retail and restaurant software suite | ||
| 14:42 | GeneDx to launch whole genome sequencing test for fetal anomalies | ||
| 14:42 | YY Group secures SGD 10.5 million banking facility from UOB | ||
| 14:42 | Baird Medical obtains regulatory approvals in Pakistan and Vietnam | ||
| 14:42 | FICO Xpress 9.8 speeds up optimization problems by 50x with NVIDIA AI | ||
| 14:42 | Arrowhead Pharma stock rating reiterated by Cantor Fitzgerald on obesity data | ||
| 14:42 | Stifel raises Becton Dickinson stock price target to $215 from $210 | ||
| 14:30 | Crohn's & Colitis Foundation invests up to $500,000 in Palisade Bio | ||
| 14:30 | US private sector adds 41,000 jobs in December, pay growth steady | ||
| 14:30 | Goldman Sachs Bank Europe discloses dealings in Permanent TSB shares | ||
| 14:30 | Exelixis and Natera to collaborate on MRD-guided cancer trial | ||
| 14:30 | FDA feedback clears path for Aspire Biopharma's heart attack drug | ||
| 14:30 | Apollo leads $3.5 billion capital solution for xAI's GPU infrastructure | ||
| 14:30 | NYSE to list MSCI index options on its exchanges in early 2026 | ||
| 14:30 | ReAlta Life Sciences appoints biotech veteran Jonathan Rigby to board | ||
| 14:30 | SOPHiA GENETICS and MD Anderson partner on AI-driven cancer care | ||
| 14:30 | Walker & Dunlop, Pretium launch $250 million affordable housing bridge fund | ||
| 14:30 | Keefe, Bruyette & Woods raises Burke & Herbert price target to $74 on acquisition | ||
| 14:30 | Compass Point initiates coverage on RPT Realty stock with Buy rating |